InvestorsHub Logo

PoemStone

11/20/11 1:23 PM

#657 RE: JetLifer #654

Jetlifer. Looking in. BOCX sheet:



VIDEO Presentation: http://biocurex.com/media/burger_scia.wmx

Nov 9, 2011. Wholly Owned Subsidiary, OncoPet Diagnostics, Signs Distribution Agreement With Webster Veterinary
http://ih.advfn.com/p.php?pid=nmona&article=49871177

Ocy 27, 2011. Generates Attention at Recent International Scientific Meeting on Cancer Markers
http://ih.advfn.com/p.php?pid=nmona&article=49692506

Oct 11, 2011. RECAF(TM) Positioned to Solve Issues With PSA Screening
http://ih.advfn.com/p.php?pid=nmona&article=49493626

Oct 4, 2011. Oncology Journal to Publish RECAF(TM) Test Results Showing Very High Sensitivity in Detection of Early Stages of Breast Cancer
http://ih.advfn.com/p.php?pid=nmona&article=49408033

Video presentation by BioCurex Chairman Dr. Denis Burger at the Southern California Investment Association.
http://biocurex.com/media/burger_scia.wmx

Also, Slide presentation by BioCurex Chairman Dr. Denis Burger at the Southern California Investment Association.
http://biocurex.com/media/burger_scia_slides.swf

And, Abbott Labs and BioCurex joint presentation of serum-RECAF results (pdf)
http://biocurex.com/media/posters/Abbott_poster.pdf

Sept 8, 2011 BioCurex's RECAFTM Blood Test for Cancer Can Prevent Two Thirds of Unnecessary Prostate Biopsies
http://biocurex.com/news/news133.htm

Aug 25, 2011 BioCurex Presents Latest Advances on Its Proprietary Peptide RECAF(TM) Test in International Cancer Congress
http://biocurex.com/news/news132.htm



BioCurex Inc.
Suite 215, 7080 River Road, Richmond, BC, V6X 1X5, Canada
Tel: (866) 884 8669 (Toll free) or (604) 207 9150
Fax (604) 207 9165
email: info@biocurex.com
http://biocurex.com/index.php

10-Q Period Ending June 30, 2011:
http://sec.gov/Archives/edgar/data/1092562/000135448811002730/bocx_10q.htm
SEC FIlings:
http://sec.gov/Archives/edgar/data/1092562/000135448811002730/0001354488-11-002730-index.htm

OncoPet Diagnostics Inc. is a wholly owned subsidiary of BioCurex, Inc., a development stage biotechnology company with proprietary and patented technologies in the area of cancer detection.
http://oncopetdiagnostics.com/index.php
New OncoPet Sample Collection Kit Ready to Ship to Distributors and Veterinarians



http://ih.advfn.com/p.php?pid=nmona&article=49304397&symbol=BOCX

Shares Outstanding 175,177,131 a/o Aug 10, 2011
Float Not Available
http://www.otcmarkets.com/stock/BOCX/company-info

O/S: 174,427,131 (December 31, 2010 - 168,188,974)
A/S: 450,000,000
iHub MB: http://investorshub.advfn.com/boards/board.aspx?board_id=2475

SLIDE SHOW: http://biocurex.com/media/burger_scia_slides.swf